Upgrade to SI Premium - Free Trial

Taysha Gene Therapies (TSHA) PT Raised to $14 at BMO Capital on Differentiation

June 23, 2026 7:00 AM
(Updated - June 23, 2026 8:46 AM EDT)

BMO Capital analyst Evan Seigerman raised the price target on Taysha ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change